STARPHARMA HOLDINGS LIMITED - News & Media

Market Cap $43.82M Add to my watchlist

Starpharma Holdings Limited is an Australia-based biopharmaceutical company. The... Starpharma Holdings Limited is an Australia-based biopharmaceutical company. The principal activities of the Company consist of research, development and commercialization of dendrimer products for pharmaceutical, life-science and other applications. It is focused on developing and commercializing novel therapeutic products that address global healthcare needs. The Company is also involved in the development of nano-scale materials, including the development of VivaGel for the management and prevention of bacterial vaginosis, and as an antiviral condom coating, and VIRALEZE, an antiviral nasal spray. The Company is also applying its proprietary dendrimers to drug delivery to create improved pharmaceuticals and has developed the valuable DEP delivery platform. VIRALEZE is a broad-spectrum nasal spray intended to provide a moisturizing and protective barrier in the nose that traps and blocks cold/respiratory viruses. It also offers VivaGel BV and VivaGel Condom products.More

Buyers (Bids)

No.	Vol.	Price($)
3	372123	9.9¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	5042	1

View Market Depth

No.	Vol.	Price($)
1	6000	0.955
4	25073	0.950
1	3925	0.945
3	8847	0.940
1	10000	0.935

Price($)	Vol.	No.
0.960	4540	2
0.965	15000	1
0.970	13906	2
0.975	10000	1
0.980	19012	1

Last trade - 16.10pm 27/09/2024 (20 minute delay)


Last 9.9¢		Change 0.000 ( 1.00 %)
Open	High	Low	Volume
10.0¢	10.0¢	9.9¢	67032
Last updated 15.59pm 27/09/2024 ?

SPL (ASX) Chart

(20min delay)
Last 9.9¢		Change 0.000(0.00%)		Mkt cap ! $43.82M